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MARGINAL BONE STABILITY AROUND BONE LEVEL
VERSUS TISSUE LEVEL IMPLANTS IN NON-COMPLIANT
PATIENTS WITH HEALTHY OR REDUCED PERIODONTIUM:
A 10-YEAR RETROSPECTIVE STUDY
Joyce Nicolas* | Nada Bou Abboud Naaman** | Johnny Nohra*** | Mark Bou Chaaya ****
Abstract
The aim of this retrospective study was to investigate the effects of bone level implants (BL) in non-compliant patients on marginal bone alterations compared with the tissue level implants group (TL) at a mean follow-up period of at least 10 years.
This study reports on 44 non-compliant patients selected from 3 private practices located in Beirut. Patients selected underwent implant surgery between
2005 and 2009 and had BL (Branemark and 3I Biomet) or TL (Straumann) implants. Periapical radiographs were taken directly after loading and at least
at 10 years later. Crestal bone loss (CBL) for a total of 140 implants, including 97 BL and 43 TL implants was measured on radiographic images using the
image tool software. Image calibration was done according to implant length. Hygiene level, smoking status and implant surface were also registered.
After a mean period of 10 years, implants in the TL group had a mean CBL of 1.18± 0.89 (0.85 on the mesial side and 1.5 on the distal side). The BL group
showed a mean CBL of 0.97 ± 0.64 (0.65 on the mesial side and 1.29 on the distal side). No significant difference (p >0.05) was found between the 2
groups. Hygiene level was significantly associated with mesial and average bone loss. TiUnite surface showed a lower distal bone loss compared to SLA
and acid etched surfaces. Furthermore, the average bone loss was significantly elevated in multiple-implant compared to single-tooth fixed implant restorations. No significant difference in bone loss was found between the maxilla and the mandible or between non-smokers and smokers.
Analysis of the obtained results did not reveal a lower bone loss between bone level and tissue level implants in patients who didn’t commit to a strict
maintenance program. However, bone loss was strongly correlated to hygiene level, confirming the importance of SPT and compliance.
Keywords: Dental implants - bone loss - periodontal treatment – dental hygiene.
IAJD 2020;11(2):75-85.

STABILITÉ OSSEUSE MARGINALE AUTOUR DES IMPLANTS « BONE
LEVEL » PAR RAPPORT AUX IMPLANTS « TISSUE LEVEL » CHEZ
LES PATIENTS NON COMPLIANTS AYANT UN PARODONTE SAIN OU
RÉDUIT : UNE ÉTUDE RÉTROSPECTIVE SUR 10 ANS
Résumé
Le but de ce travail était d’évaluer rétrospectivement, et après au moins 10 ans de fonction, les changements du niveau osseux crestal autour des implants
«niveau osseux» par opposition aux implants «niveau muqueux» chez des patients qui n’ont pas suivi un programme de maintenance parodontale.
Les dossiers médicaux des patients de trois cabinets privés à Beyrouth ont été analysés. Les patients qui ont subi une chirurgie implantaire depuis 10
ans (entre 2005 et 2008), recevant des implants Straumann «niveau muqueux»(TL) ou Branemark/3i Biomet «niveau osseux» (BL) et n’ayant pas suivi un
programme de maintenance ont été évalué. 44 patients ont été inclus dans l’étude, et les radiographies prises directement après mise en charge et après
10 ans ont été comparées. La standardisation des radios a été réalisée selon la longueur de l’implant. D’autres paramètres ont été enregistrés comme le
niveau d’hygiène, le tabagisme et la surface implantaire.
Au total, 140 implants comprenant 97 implants BL and 43 implants TL ont été inclus dans cette étude. Après 10 ans de mise en charge, le groupe TL a
présenté une perte osseuse moyenne de 1.18± 0.89 (0.85 en mésial et 1.5 en distal) alors que le groupe BL a montré une perte osseuse moyenne de
0.97 ± 0.64 (0.65 en mésial et 1.29 en distal). Les études statistiques n’ont pas montré de différences significatives (p >0.05) entre les groupes. Une
corrélation positive a été révélée entre la perte osseuse et le niveau d’hygiène. La surface implantaire TiUnite a montré une perte osseuse moindre en
distal comparée aux autres surfaces. Par contre, nos résultats n’ont pas pu montrer une différence significative dans la perte osseuse entre le maxillaire et
la mandibule ou une corrélation avec le tabagisme.
L’analyse des résultats n’a pas montré une résorption osseuse marginale moindre entre les implants BL et TL chez les patients n’ayant pas suivi un protocole de maintenance parodontale. Toutefois, la perte osseuse est corrélée à l’hygiène buccale d’où l’importance de la maintenance.
Mots-clés: implant dentaire - perte osseuse marginale - maintenance parodontale.
IAJD 2020;11(2):75-85.
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Introduction
Over the past decades, implant
therapy has been used as an alternative to conventional prosthetic rehabilitation in partially or totally edentulous patients. It is proved that implant
therapy has a long term high success
and survival rates and is considered as
the treatment of choice for replacing
missing teeth [1-3] 1–3.
One important parameter for evaluating treatment outcome and longterm success is peri-implant crestal
bone loss (CBL)[1]1. It is accepted
that, during the first year of loading,
CBL around implants is inevitable
and is considered as an adaptive response to surgical trauma and loading
[1, 2]1,2. After the first year of loading,
the marginal bone level is more stable,
and most implants show minimal
annual CBL. According to established
criteria for the assessment of implant
survival and success, CBL in the first
year should be lower than 1.5 mm, and
ongoing annual bone loss should be
lower than 0.2 mm [4,5]4,5. However,
some implants will show more bone
loss than others and a few will even
show continuous loss over time, this
would be related to an infectious process, i.e., periimplantitis[1,2,6]1,2,6.
Lang et al. in 2011, suggested that the
incidence of biologic complications,
and more speciﬁcally of peri-implantitis, may be up to 50% [7]7. Recently,
it was suggested that CBL around
implants is influenced by many factors [1]1, like systemic diseases (smoking and diabetes) [8]8, soft tissue
thickness [9]9,inter-implant distanc e
[10]10, implant surface [11]11, crown–
implant ratio [12]12, implant system
used [13]13, implant neck design
[6,14,15]6,14,15, implant location
[16]16, antagonistic occlusion [17]17,
characteristics of the prosthesis [4]4,
mode of retention [18]18.
It is important to note that subjects
receiving implants ought to have healthy oral conditions before any surgery
and need to be included in a well-structured maintenance program [3,7]3,7.
Periodontally compromised patients

Fig. 1: Schematic representation of the radiographic analysis used to standardize the
radiograph and determine the bone level applied on BL and TL implants.
MIS: Mesial implant shoulder, DIS: Distal implant shoulder, A: Line connecting MIS
and DIS, B: Line tangential to the implant apex and parallel to A, DIL: Distorted
implant length - bisecting line of the angle of A and B, BIC: Most coronal visible boneto-implant contact, BL: Bone loss.

(PCP) are patients experiencing continuing tooth loss due to uncontrolled
periodontal disease and following no
supportive periodontal therapy (SPT)
[1]1. Hardt et al., in their 5-year retrospective study in 2002, reported a failure rate of 8% for PCP compared with
3% for periodontally healthy patients
(PHP) [19]19. More studies showed
that implants can successfully be used
in PCP who have received periodontal
therapy and regularly obtain SPT, but
the rate of both biological complications and implant failure is greater
in PCP group [21,22] 21,22. There is
no consensus on the best frequency
of SPT. According to Miyamoto et al.,
all patients who demonstrated any
pocket depth (PD) ≥4 mm were assigned to 3-month intervals of maintenance, otherwise, the patients were
assigned to 6-month intervals of SPT
[23,24]23,24. Armitage et al. suggested
2–3 months intervals in individuals at
high risk of disease recurrence, whereas, longer intervals are sufficient to
PHP. In addition, longitudinal clinical results showed that SPT at 3- to
4-month intervals works for most individuals [25]25.

Moreover, there is little evidence on
the difference in behavior of bone level
(BL) versus tissue level (TL) implants
in non-compliant patients, although
both implant types have been proven successful. Conventionally, BL
implants are placed at the bone crest
and the implant-abutment microgap is located at the bone crest
[5]5. Whereas, TL implants are typically placed transmucosally, and the
implant-abutment micro-gap is coronal to the bone crest [26]26. The distance from the gingival margin to the
bone crest around implants, i.e., the
implanto-gingival unit, has been found
to be a physiologically formed stable
structure. The CBL has been attributed
to various factors and one of which is
the presence of bacterial infiltration at
the microgap [27]27. When the crownimplant junction is beneath the bone
crest, the re-establishment of the protective environment, the biological
width, causes a non-physiological response that initiates bone loss. With TL
implants, and because of the existence
of a smooth–rough surface interface on
the implant itself, bone loss occurring
up to that interface can be considered
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Fig. 2: Radiographic analysis applied
on bone level implants.

physiological remodeling, while bone
loss occurring apical to that point can
hence be regarded as pathological
[11]11. It has been suggested that the
transmucosal location of the microgap
in TL implants seems to be advantageous because it is positioned at a distance from the bone crest [5]5.
Nonetheless, there is little evidence on the long-term prognosis of
implants in non-compliant patients.
Wilson defined compliance as "personal conduct with respect to the recommendations received from the health
professional" [28]28. Compliance is
calculated based on the total number
of recall visits attended and the individually prescribed follow-up intervals.
Different classifications have been
suggested, Checchi et al. in 1994 divided patients in three groups: insufficient compliance (attended<50% of
prescribed recall visits); partial compliance (attended <100% and >50% of
recall visits); and complete compliance
(attended all recall visits) [29,30]29,30.
According to Zeza et al. a patient is
compliant if he skips less than 30% of
his appointments [30]30.

Fig. 3: Radiographic analysis applied
on tissue level implants.

Wang et al. evaluated retrospectively bone alterations in non-compliant
patients, and the effects of uncontrolled periodontitis (without SPT) on
CBL around TL implants compared to
PHP over 6 years. The results showed
no differences in bone loss around TL
implants between PHP and PCP [1]1.
The primary aim of the present
retrospective study was to compare
CBL for BL and TL implants in noncompliant patients after a follow-up
period of at least 10 years. The secondary end goal was to compare the
influence of hygiene level, smoking
status and implant surface on CBL in
the same conditions.

Materials and methods
Population screening
The study protocol was approved by the Ethics Committee and the
research Council at the Saint Joseph
University of Beirut and allocated the
number USJ-2018-61.
Patients who underwent implant
surgery 10 years ago (between 2005
and 2008) were screened from 3 private practices located in Beirut and

selected for the study when they met
the following inclusion criteria: i)
having received the initial phase then
implants in the posterior region and
were lost to follow-up; ii) implants
were placed more than 10 years ago;
iii) Straumann Tissue Level implants
(Straumann Dental Implants System,
Switzerland) and Branemark / 3i
Biomet Bone Level external hexagon
implants, iv) non-compliant patients,
who attended 7 or less visits in the 10
years follow-up [30]30; and v) smoking
≤ 10 cigarettes/day.
Exclusion criteria were as follow:
i) systemic health problems (uncontrolled diabetes, medication that may
affect bone metabolism); ii) completely edentulous patients; iii) untreated
periodontitis; iv) unavailability or inappropriate radiographs; v) augmented
sites; and vi) extraction and immediate
implant placement.
Radiographic parameters
Radiographic measurements were
performed on periapical radiographs processed using the image tool
software DBSWIN system® (Durr
Dental, Baden-Wurttemberg, Germany)
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for CBL as illustrated in Figure 1.
Standardization was done according
to implant length. The mesial and distal implant shoulders (MIS-DIS) were
defined and a line (A) connecting both
was drawn. Another line (B) tangential to the implant apex and parallel
to (A) was also drawn. The bisecting
line of the angle of (A) and (B) was
therefore produced and measured to
evaluate the distorted implant length
(DIL). Knowing the actual length of
the implant, the software delivers a
calibration factor and automatically
computed all measured distances in
real values, eliminating the distortion
factor.
Then, bone level (BL) measurements were recorded from the implant
platform/shoulder mesially (MIS) and
distally (DIS) to the most coronal
visible bone-to-implant contact (BIC)
on the mesial and distal sides of each
implant. The mesial bone level postloading (MBL0), distal bone level postloading (DBL0), mesial bone level after
10 years (MBL10), and distal bone level
after 10 years (DBL10) were recorded.
Finally, the 10 years bone loss measurements were calculated by subtracting
the values obtained from periapical
radiographs at loading and at 10 years,
both at the mesial (MBL) and the distal side (DBL), and the mean of the
distal and mesial measures was considered average bone loss (ABL) around
the implant (Figures 2 and 3 illustrate
an example of the measurements performed on the periapical radiographs).
Radiographs of 33% of implants (40
implants) were selected for the second
analysis of the CBL to assess the inter
examiner variability.
Clinical parameters
Other variables were noted: i)
Mandibular or maxillary location of
implants; ii) Hygiene level (Poor, fair or
good); iii) Smoking status (light smokers < 10 cig/day or heavy smokers > 10
cig/day); iv) Single or multiple implant
restorations; v) Years in function; and,
vi) Implant surface.

N

Mean ± Std. Deviation

ICC with 95% confidence interval

DIL- J.N. (mm)

50

49.24 ±27.23

0.999 (0.999 - 1.000)

DIL- M.C. (mm)

50

49.29 ± 27.22

BL D after 10 yrs J.N. (mm)

50

1.35 ± 0.68

BL D after 10 yrs M.C. (mm)

50

1.35 ± 0.67

0.979 (0.963 – 0.988)

Table 1: Reproducibility of measurements between examiners.

Statistical analysis
The IBM SPSS statistics (version
25.0) was used to perform the statistical analyses. The alpha error was
set at 0.05. Reproducibility of measurements was evaluated using the
Intraclass correlation coefficient (ICC).
The normality distribution of continuous variables was assessed using
Kolmogorov-Smirnov tests. Repeatedmeasures analysis of variance was
used to compare mesial and distal
bone loss between different implant
systems.
Analysis of variance followed by
Tukey post-hoc tests and KruskalWallis tests were used to compare
continuous variables between three
groups. Student t-tests and MannWhitney tests were used to compare
continuous variables between two
groups.

Results
Reproducibility between
measurements
Reproducibility between measurements was tested using the intraclass
correlation coefficient ICC); the ICC
was very high indicating an excellent
reproducibility.
Description of the study population
In total, 44 patients were included
in the study (table 2), 140 implants,
including 97 Bone Level (3i Biomet/
Branemark) implants and 43 Tissue
Level (Straumann) implants were analyzed. Twenty-one (47.7%) patients had

a good oral hygiene and 13(29.5%) had
a low oral hygiene. Only 10 (22.7%)
patients were smokers (8 light and 2
heavy smokers). Implants length and
diameter are showed in table 3.
Comparison between mesial and
distal bone loss
Mesial bone loss (MBL) was 0.68 ±
0.74, 0.61 ± 0.83, and 0.85 ± 1.25 for 3i
BL, Branemark BL and Straumann TL,
respectively. Distal bone loss (DBL)
was 1.45 ± 0.74, 1.10 ± 0.84, and 1.50 ±
0.80 for 3i, Branemark and Straumann
TL, respectively. Average bone loss
(ABL) was 1.07 ± 0.61, 0.856 ± 0.67, and
1.18 ± 0.89 for 3i BL, Branemark BL and
Straumann TL, respectively (Table 4).
Bone loss was significantly greater
on the distal side of the implant for 3i
Biomet system (p<0.001), Branemark
(p=0.001) and Straumann TL (p<0.001).
MBL was not significantly different
between the 3 implants systems
(p=0.48), however, on the distal side,
bone loss was statistically lower with
Branemark implants (p=0.04) while the
difference was not significant between
3i Biomet and Straumann TL implants
(p=1.000).
Factors associated with CBL around
implants after 10 years period
Our data revealed that MBL
(p=0.71) and DBL (p=0.18) was not
significantly different between the
maxilla and the mandible. Moreover,
implant system was not significantly
associated with MBL (p=0.24) and
DBL (p=0.16). Also, MBL (p=0.93) and

79
Parodontologie / Periodontology
Frequency

Percentage

Maxillary

61

43.6

Mandible

79

56.4

Acid etched 3i Biomet

52

37.1

TiUnite Branemark

45

32.1

SLA Straumann

43

30.7

Bone Level

97

69.3

Tissue Level

43

30.7

Unitary

47

33.6

Multiple

93

66.4

Arch

Implant surface and system

Implant type

Restoration

Table 2: Distribution of the 140 implants.

DBL (p=0.53) were not significantly
different between non-smokers and
smokers.
On the other hand, hygiene level
was significantly associated with
MBL (p=0.01) and ABL (p=0.02).
Furthermore, the ABL was significantly
higher in bridge restoration compared
to single-unit restoration (p=0.04).

Discussion
The primary aim of the current
study was to compare, in non-compliant patients, CBL between BL and
TL implants, after 10 years of follow
up.
Patients usually seek professional
service for active treatment because of
the symptoms of the disease, nevertheless, many studies have shown that
patients’ compliance with SPT is generally insufficient with a percentage
of 19.6 to 34% of patients being noncompliant
[13,28,29,31]13,28,29,31.
The disappointing behavior of patients

during SPT suggests that the health
professional should be more aggressive in motivating patients [28]28.
As for the comparison of BL and TL
implants after 10 years of function, our
study couldn’t prove a difference in the
CBL between TL and BL implants in
non-compliant patients, and implant
type was not significantly associated
with mesial, distal and mean bone
loss. Data showed a higher bone loss
around TL implants, but the difference
was not statistically significant and
a larger sample must be considered
for more investigation. In 2017, Rokn
et al. aimed to evaluate the prevalence of biologic complications of TL
and BL implants without regular SPT.
The results showed a significant difference in mean CBL between TL and BL
implants. After 5 years of loading, TL
implants had lower values of periimplantitis prevalence and CBL [37]37. In
2018, Wallner et al. investigated bone
loss around TL and BL implant sites
in the esthetic zone. They concluded

that peri-implant bone height did not
depend on implant design [27]27.
Their results are in accordance with the
current study. In a systematic review,
Vouros et al. in 2012, showed no statistically significant differences in bone
loss between BL and TL implants over
a period of 1 to 3 years [5]5.
Bone loss was significantly greater on the distal side of the implant
for 3i Biomet system, Branemark and
Straumann TL. Different techniques
have been used in the literature for the
radiographic measurements. Some studies used the ABL between mesial and
distal side [4,12,17,38,39]4,12,17,38,39,
others used each side of the implant
(mesial and distal) as a unit [35]35
and others considered the site with
the greatest bone loss as the representative of each implant [37]37. In their
study in 2009, Linkevicius et al. used
the mesial side and the distal side,
then they calculated the bone loss
on both sides and on average [9]9.
Radiographic measurements revealed
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Implant System
3i Biomet

Implant diameter (mm)

Implant length (mm)

Frequency

Percent

3.25

13.0

1

100.0

3.75

8.5

2

10.0

10.0

9

45.0

11.5

7

35.0

13.0

1

5.0

15.0

1

5.0

Total

20

100.0

8.5

1

3.4

10.0

17

58.6

11.5

6

20.7

13.0

4

13.8

15.0

1

3.4

Total

29

100.0

10.0

1

50.0

11.5

1

50.0

Total

2

100.0

8.5

1

6.3

10.0

5

31.3

11.5

6

37.5

13.0

3

18.8

15.0

1

6.3

Total

16

100.0

8.5

1

4.8

10.0

14

66.7

11.5

5

23.8

13.0

1

4.8

Total

21

100.0

8.5

1

12.5

10.0

4

50.0

11.5

3

37.5

Total

8

100.0

3.30

10.0

1

100.0

4.10

8.0

1

4.0

10.0

10

40.0

12.0

14

56.0

Total

25

100.0

8.0

2

11.8

10.0

11

64.7

12.0

4

23.5

Total

17

100.0

4.00

5.00

Branemark

3.75

4.00

5.00

Straumann

4.80

Table 3: Implants diameter and length description.
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3i Biomet (Acid etched)
(N=52)

Branemark (TiUnite)
(N=45)

Straumann TL (SLA)
(N=43)

p-value

Mesial Bone Loss

0.68 ± 0.74

0.61 ± 0.83

0.85 ± 1.25

0.48

Distal Bone loss

1.45 ± 0.74b

1.10 ± 0.84a

1.50 ± 0.80b

0.04

p-value

<0.001

0.001

<0.001

Average bone loss

1.07 ±0.61

0.856 ±0.67

1.18 ±0.89

0.11

Table 4: Calculated bone loss for the 3 different implant systems at 10 years.
a, b: Different letters indicate the presence of a significant difference according to Tukey post-hoc tests.

Bone loss around implants
Mesial Bone loss Distal Bone loss Average Bone loss

2.5

Mean (mm)

2
1.5
1
0.5
0
3i

Branemark

Strauman TL

Table 5: ABL around the 3 different implant systems.

variations in the extent of bone loss
between mesial and distal sites, as it
was showed in our study. These differences can be explained by the fact
that a flat alveolar ridge is not always
available at the implantation site, as
some implants can be placed on the
ascending alveolar ridge. This resulted
in different implant-abutment junction
positions mesio-distally in relation to
the bone crest [9]9.
Moreover, the purpose of surface
modification of implant surfaces is to
positively affect the host-to-implant
tissue response. The modification
methods can be divided into subtractive (i.e. blasting, etching or oxidation)
and additive processes (i.e. titanium
plasma spraying) [40]40. TPS surface
was a common surface over a decade
ago. Later, a sandblasted and acid-

etched (SLA) surface was confirmed
to yield an excellent survival rate. The
TPS surface has an increased surface
roughness compared to SLA. This
feature should be particularly important in PCP, because micro-roughness
is an important factor influencing
the amount of plaque accumulation
[35]35. In our study, the MBL and ABL
didn’t show any significant difference
between the different implant surfaces. Our study shows the lowest MBL
on the TiUnite, followed by the acid
etched surface then by the SLA surface. The DBL was significantly lower
on TiUnite compared to other implant
surfaces. Dam et al in 2014 also proved
that the SLA surface showed less bone
loss than the TPS (P < 0.05) [11]11. In
Berglundh’s experiment in 2007, the
radiographic examinations indicated

that similar amounts of bone loss
occurred at SLA and polished surface
sites during the active breakdown
period, while the progression of bone
loss was larger at SLA than at polished
sites following ligature removal. It is
suggested that the progression of periimplantitis, if left untreated, is more
pronounced at implants with a moderately rough surface than at implants
with a polished surface [41]41. This
is in accordance with Doornewaard’s
review that suggests that CBL around
minimally rough implant systems
was significantly lower in comparison
to the moderately rough and rough
implant systems [42]42. In addition,
De Bruyn et al demonstrated that SLA
surface implants yielded less CBL than
turned surfaces or TiUnite surface
implants [40]40.
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Mesial Bone Loss
(MBL)

Distal Bone Loss
(DBL)

Average Bone loss
(ABL)

Maxillary

0.75± 0.92

1.25± 0.81

0.99 ± 0.73

Mandible

0.69 ± 0.98

1.44 ± 0.80

1.06 ± 0.74

p

0.71

0.18

0.62

Bone level

0.65 ± 0.78

1.29 ± 0.81

0.97 ± 0.64

Tissue level

0.85 ± 1.25

1.50 ± 0.80

1.18 ± 0.89

P

0.24

0.16

0.12

Good

0.65 ± 0.81

1.33 ± 0.75

0.99 ± 0.64a

Moderate

0.33 ± 1.29

1.23 ± 0.82

0.77 ± 0.88a

Fair

1.03 ± 0.92

1.56 ± 0.83

1.30 ± 0.73b

p

0.01

0.09

0.02

Unitary

0.61 ± 1.25

1.20 ± 0.87

0.91 ± 0.93

Multiple

0.76 ± 0.75

1.43 ± 0.77

1.10 ± 0.60

p

0.37

0.11

0.04

No

0.72 ± 0.86

1.3 8± 0.80

1.05 ± 0.69

Light / Heavy

0.70 ± 1.31

1.27 ± 0.87

0.98 ± 0.89

p

0.93

0.53

0.68

Arch

Implant type

Hygiene level

Restoration

Smoking status

Table. 6: ABL around the 3 different implant systems.

In our study, hygiene level was
significantly associated with mesial
and average bone loss. The hygiene
evaluation was subjective and cannot
be conclusive but still underlines the
importance of complying with a strict
SPT program to maintain bone level
around implants.
Smoking was identified as a strong
risk factor associated with peri-implant
diseases, affecting the long prognosis
of oral implants, a significantly greater failure rate in smokers was reported when compared to nonsmokers
in a 6-year follow-up study [43]43. In
our study, bone loss was not significantly different between non-smokers
and smokers, the low percentage of

smokers (22.7%) may have corroborated to better results and less bone
loss. Dam et al showed that, after at
least 5 years, CBL increased, approximately, for more than 25% in smokers.
Implants in smokers showed a statistically higher values of CBL, over 1.5 mm
than implants in non-smokers [11]11.
Urdaneta et al also found a positive
correlation between smoking and bone
loss stating that a TPS-coated mandibular implant will more likely lose
bone if the patient is a smoker [17]17.
Karoussis et al. showed that smoking
PCP yields a documented higher risk
for implant loss than the non-smoking
PCP or the PHP [43]43. In a prospective
study, patients undergoing a success-

ful smoking cessation protocol showed
significantly higher implant-success
rates compared to patients who continued smoking after implant placement. Therefore, the dentist should
motivate the smokers for smoking cessation during the SPT sessions [43]43.
Furthermore, it has been proposed
that splinting implant restorations
could provide a better distribution of
the occlusal forces among the inserted
implants [12]12. Therefore, the effect of
stress-related factors such as the type
of opposing structure may be more
significant around single implants
than on splinted implants [17]17.
Splinting has been recommended
in the prosthetic rehabilitation of

83
Parodontologie / Periodontology
implants placed in the posterior jaw in
order to reduce CBL. However, the use
of single units offers some advantages
like better emergence profiles, improved passive fit of the metal framework
and better oral hygiene access [17]17.
In our study, 66.4% of the implant restorations were splinted. The results
showed that the MBL, DBL and ABL
were more elevated in the multipleimplant restoration group. In fact, the
ABL was significantly more elevated in
bridge restoration compared to singleimplant restoration. The disproportion
of sample could have tampered the
results.
Finally, this study revealed that
MBL, DBL and ABL were not significantly different between the maxilla
and the mandible. There was a
tendency for more bone loss in the
mandible however, the difference was
not statistacally significant. This is in
agreement with Urdaneta et al in 2014
where higher CBL around mandibular
implants was shown compared with
maxillary implants [17]17.
There are some limitations for this
study. First, as it is a retrospective
study, there was a lack of proper radiographic standardization. The radiographs were not free of distortion, as the
surrounding tissues inevitably create a
certain distance between the films and
the implant body. A prospective study
with standardized radiographs would
offer more precise results. Second,
the measurement method in the study
involved the risk of personal bias, as
it was based on the examiners’ impartiality when determining bone height
values. With two repeated measurements at each site of the radiographic
images, the appearance of errors has
been kept to a minimum. In addition, the positive long-term outcomes
may also have benefited from the fact
that all implants were placed by experienced implant surgeons. The benefit
is that subjects recruited from private
clinics, rather than university clinics,
provide information on the ‘‘effectiveness’’ rather than the ‘‘efficacy’’ of
implant therapy.

Conclusions and
perspectives
Today, poor oral hygiene is known
as an important risk factor in the
development and progression of periimplant disease. It is of major importance to put every implant patient
in a strict SPT program to maintain
implant health. Besides, there is little
evidence on the difference in behavior
of BL versus TL implants in non-compliant patients. In this study, after a
mean period of 10 years, no significant
difference (p >0.05) in CBL was found
between TL and BL implants in noncompliant patients. Hygiene level was
significantly associated with marginal
bone loss.
Future research with larger
samples is necessary to get more precise outcomes for a better comparison
between bone level and tissue level
implants in non-compliant patients.
Furthermore, the difference in bone
loss between the mesial and distal side
of the implant should be questioned.

84

IAJD Vol. 11 – Issue 2

Article scientifique | Scientific Article

References
1. Wang X, Qin L, Lei C, Li Y, Li D. Effects of uncontrolled
periodontitis on marginal bone alterations around implants: A
case-control study. Clin Implant Dent Relat Res. 2017;19(4):654662.

16. Horwitz J, Zuabi O, Peled M, Machtei EE. Immediate and
delayed restoration of dental implants in periodontally
susceptible patients: 1-year results. Int J Oral Maxillofac
Implants. 2007;22(3):423-429.

2. Buser D, Sennerby L, De Bruyn H. Modern implant dentistry
based on osseointegration: 50 years of progress, current trends
and open questions. Periodontol 2000. 2017;73(1):7-21.

17. Urdaneta RA, Leary J, Panetta KM, Chuang SK. The effect of
opposing structures, natural teeth vs. implants on crestal bone
levels surrounding single-tooth implants. Clin Oral Implants
Res. 2014;25(2):179-188.

3. Albrektsson T, Donos N. Implant survival and complications. The
Third EAO consensus conference 2012. Clin Oral Implants Res.
2012;23(SUPPL.6):63-65.
4. Türk AG, Ulusoy M, Toksavul S, Güneri P, Koca H. Marginal bone
loss of two implant systems with three different superstructure
materials: A randomised clinical trial. J Oral Rehabil.
2013;40(6):457-463.
5. Vouros IS, Kalpidis C, Horvath A PA, N D. and Tissue-level
endosseous dental Implants. Int J Oral Maxillofac Implants.
2012:1359-1374.
6. Bratu EA, Tandlich M, Shapira L. A rough surface implant
neck with microthreads reduces the amount of marginal bone
loss: A prospective clinical study. Clin Oral Implants Res.
2009;20(8):827-832.
7. Lang NP, Berglundh T. Periimplant diseases: Where are we
now? - Consensus of the Seventh European Workshop on
Periodontology. J Clin Periodontol. 2011;38(SUPPL.11):178-181.
8. Turri A, Rossetti P, Canullo L, Grusovin M, Dahlin C. Prevalence
of peri-implantitis in medically compromised patients and
smokers: A systematic review. Int J Oral Maxillofac Implants.
2016;31(1):111-118.
9. Linkevicius T, Apse P, Grybauskas S, Puisys A. The influence of
soft tissue thickness on crestal bone changes around implants:
a 1-year prospective controlled clinical trial. Int J Oral Maxillofac
Implants. 2009;24(4):712-719.
10. Tarnow DP, Cho SC, Wallace SS. The effect of inter-implant
distance on the height of inter-implant bone crest. J Periodontol.
2000;71(4):546-549.
11. Dam HG, Najm SA, Nurdin N, Bischof M, Finkelman M, Nedir
R. A 5- to 6-year radiological evaluation of titanium plasma
sprayed/sandblasted and acid-etched implants: Results from
private practice. Clin Oral Implants Res. 2014;25(2):159-165.
12. Blanes RJ, Bernard JP, Blanes ZM, Belser UC. A 10-year
prospective study of ITI dental implants placed in the posterior
region. II: Influence of the crown-to-implant ratio and different
prosthetic treatment modalities on crestal bone loss. Clin Oral
Implants Res. 2007;18(6):707-714.
13. Puchades-Roman L, Palmer RM, Palmer PJ, Howe LC, Ide
M, Wilson RF. A clinical, radiographic, and microbiologic
comparison of Astra Tech and Brånemark single tooth implants.
Clin Implant Dent Relat Res. 2000;2(2):78-84.

18. Goh EXJ, Lim LP. Implant maintenance for the prevention of
biological complications: Are you ready for the next challenge?
J Investig Clin Dent. 2017;8(4):1-9. doi:10.1111/jicd.1225
19. Hardt CRE, Gröndahl K, Lekholm U, Wennström JL. Outcome
of implant therapy in relation to experienced loss of periodontal
bone support: A retrospective 5-year study. Clin Oral Implants
Res. 2002;13(5):488-494.
20. Aguirre-Zorzano LA, Vallejo-Aisa FJ, Estefanía-Fresco R.
Supportive periodontal therapy and periodontal biotype as
prognostic factors in implants placed in patients with a history
of periodontitis. Med Oral Patol Oral Cir Bucal. 2013;18(5).
21. Ellegaard B, Baelum V, Karring T. Implant therapy in periodontally
compromised patients. Clin Oral Implants Res. 1997;8(3):180188.
22. Karoussis IK, Salvi GE, Heitz-Mayfield LJA, Bragger U, Hammerle
CHF, Lang NP. Long-term implant prognosis in patients with and
without a history of chronic periodontitis: a 10-year prospective
cohort study of the ITIR Dental Implant System. Clin Oral
Implants Res. 2003;14(3):329-339.
23. Miyamoto T, Kumagai T, Lang MS, Nunn ME. Compliance as a
prognostic indicator. II. Impact of patient’s compliance to the
individual tooth survival. J Periodontol. 2010;81(9):1280-1288.
24. Miyamoto T, Kumagai T, Jones JA, Van Dyke TE, Nunn ME.
Compliance as a prognostic indicator: retrospective study of
505 patients treated and maintained for 15 Years. J Periodontol.
2006;77(2):223-232.
25. Armitage GC, Xenoudi P. Post-treatment supportive care for
the natural dentition and dental implants. Periodontol 2000.
2016;71(1):164-184.
26. Hermann JS, Cochran DL, Nummikoski P V., Buser D. Crestal bone
changes around titanium implants. A radiographic evaluation
of unloaded non-submerged and submerged implants in the
canine mandible. J Periodontol. 1997;68(11):1117-1130.
27. Wallner G, Rieder D, Wichmann M, Heckmann S. Peri-implant
bone loss of tissue-level and bone-level implants in the esthetic
zone with gingival biotype analysis. Int J Oral Maxillofac
Implants. 2018;33(5):1119-1125.
28. Novaes AB, Lima FR de. Compliance with supportive periodontal
therapy and its relation to the bleeding index. J Periodontol.
1990;67(10):976-980.

14. Hansson S. The implant neck: smooth or provided with retention
elements. A biomechanical approach. Clin Oral Implants Res.
1999;10(5):394-405.

29. Checchi L, Pelliccioni GA, Gatto MRA, Keiescian L. Patient
compliance with maintenance therapy in an Italian periodontal
practice. J Clin Periodontol. 1994;21(5):309-312.

15. Shin Y-K, Han C-H, Heo S-J, Kim S, Chun H-J. Radiographic
evaluation of marginal bone level around implants with different
neck designs after 1 year. Int J Oral Maxillofac Implants.
21(5):789-794.

30. Zeza B, Pilloni A, Tatakis DN, Mariotti A, Di Tanna GL, Mongardini
C. Implant patient compliance varies by periodontal treatment
history. J Periodontol. 2017;88(9):846-853.

85
Parodontologie / Periodontology

31. Cardaropoli D, Gaveglio L. Supportive periodontal therapy and
dental implants: An analysis of patients’ compliance. Clin Oral
Implants Res. 2012;23(12):1385-1388.
32. Aguirre-Zorzano LA, Estefanía-Fresco R, Telletxea O, Bravo M.
Prevalence of peri-implant inflammatory disease in patients
with a history of periodontal disease who receive supportive
periodontal therapy. Clin Oral Implants Res. 2015;26(11):13381344.
33. Costa FO, Takenaka-Martinez S, Cota LOM, Ferreira SD, Silva
GLM, Costa JE. Peri-implant disease in subjects with and
without preventive maintenance: A 5-year follow-up. J Clin
Periodontol. 2012;39(2):173-181.
34. Roccuzzo M, Bonino L, Dalmasso P, Aglietta M. Long-term
results of a three arms prospective cohort study on implants
in periodontally compromised patients: 10-year data around
sandblasted and acid-etched (SLA) surface. Clin Oral Implants
Res. 2014;25(10):1105-1112.
35. Roccuzzo M, De Angelis N, Bonino L, Aglietta M. Ten-year
results of a three-arm prospective cohort study on implants in
periodontally compromised patients. Part 1: Implant loss and
radiographic bone loss. Clin Oral Implants Res. 2010;21(5):490496.
36. Tan WC, Ong MMA, Lang NP. Influence of maintenance
care in periodontally susceptible and non-susceptible
subjects following implant therapy. Clin Oral Implants Res.
2017;28(4):491-494.
37. Rokn A, Aslroosta H, Akbari S, Najafi H, Zayeri F, Hashemi K.
Prevalence of peri-implantitis in patients not participating in
well-designed supportive periodontal treatments: a crosssectional study. Clin Oral Implants Res. 2017;28(3):314-319.
38. Buser D, Janner SFM, Wittneben JG, Brägger U, Ramseier CA,
Salvi GE. 10-year survival and success rates of 511 titanium
implants with a sandblasted and acid-etched surface: A
retrospective study in 303 partially edentulous patients. Clin
Implant Dent Relat Res. 2012;14(6):839-851.
39. Linkevicius T, Puisys A, Steigmann M, Vindasiute E,
Linkeviciene L. Influence of vertical soft tissue thickness on
crestal bone changes around implants with platform switching:
A comparative clinical study. Clin Implant Dent Relat Res.
2015;17(6):1228-1236.
40. De Bruyn H, Christiaens V, Doornewaard R, et al. Implant surface
roughness and patient factors on long-term peri-implant bone
loss. Periodontol 2000. 2017;73(1):218-227.
41. Berglundh T, Gotfredsen K, Zitzmann NU, Lang NP, Lindhe J.
Spontaneous progression of ligature induced peri-implantitis
at implants with different surface roughness: An experimental
study in dogs. Clin Oral Implants Res. 2007;18(5):655-661.
42. Doornewaard R, Christiaens V, De Bruyn H, et al. Long-term
effect of surface roughness and patients’ factors on crestal
bone loss at dntal implants. A systematic review and metaanalysis. Clin Implant Dent Relat Res. 2017;19(2):372-399.
43. Albrektsson T, Chrcanovic B, Östman PO, Sennerby L. Initial and
long-term crestal bone responses to modern dental implants.
Periodontol 2000. 2017;73(1):41-50.

